GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » EBITDA Margin %

HLB Science (XKRX:343090) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. HLB Science's EBITDA for the three months ended in . 20 was ₩0.00 Mil. HLB Science's Revenue for the three months ended in . 20 was ₩0.00 Mil. Therefore, HLB Science's EBITDA margin for the quarter that ended in . 20 was 0.00%.


HLB Science EBITDA Margin % Historical Data

The historical data trend for HLB Science's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science EBITDA Margin % Chart

HLB Science Annual Data
Trend Dec22 Dec23
EBITDA Margin %
- -

HLB Science Quarterly Data
EBITDA Margin %

Competitive Comparison of HLB Science's EBITDA Margin %

For the Biotechnology subindustry, HLB Science's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Science's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where HLB Science's EBITDA Margin % falls into.



HLB Science EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

HLB Science's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1591.005/0
= %

HLB Science's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Science  (XKRX:343090) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


HLB Science EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of HLB Science's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines